MTWC for Fibrosing Lung Disease Lecture Series – Adaptive and Platform Trials: Can we REMAP-ILD? | Events


We are delighted to be able to inform you of a special seminar for the Margaret Turner Warwick Center for Fibrosing Lung Disease Lecture Series to be held online only at tuesday 29 March at 4 p.m. and who will see us welcome the guest speaker Dr. Roger Lewis, Principal Medical Scientist for Berry Consultants.

Talk about the details as follows:-

Talk title: Adaptive and Platform Trials: Can we REMAP-ILD?

Date: Monday 29and March

Talk time: 4:00 p.m. – 5:00 p.m. UK time

Location: Online – Microsoft Teams

Organic :

Roger J. Lewis, MD, PhD, is the Principal Medical Scientist at Berry Consultants. He received his doctorate in biophysics in 1986 and his doctorate in medicine in 1987 from Stanford University. He completed his clinical training in emergency medicine in 1990 and is currently a professor at UCLA’s David Geffen School of Medicine and chairman of the Department of Emergency Medicine at Harbor-UCLA Medical Center. Dr. Lewis’ expertise is centered in clinical research methodology, including adaptive and Bayesian assay design, and he is involved in the design and analysis of numerous laboratory, clinical and service research studies. health. His areas of interest include adaptive and Bayesian clinical trials; test platforms; translational, clinical, health services and outcomes research; emergency department overcrowding and disaster preparedness, analysis of provisional data; the role and function of data monitoring committees; and the difficulties surrounding informed consent in emergency research studies. Dr. Lewis has been a research mentor to many fellows and junior faculty and frequently lectures on the topics of clinical research design and statistical analysis of clinical trials.

In 2009, Dr. Lewis was elected a Fellow of the National Academy of Medicine (formerly the Institute of Medicine) of the National Academies. He is past president of the Society for Academic Emergency Medicine (SAEM) and a board member of the Society for Clinical Trials.

Dr. Lewis has served as a grant reviewer for the Agency for Healthcare Research and Quality (AHRQ), the Canadian Institutes of Health Research (CIHR), the Centers for Disease Control and Prevention (CDC), the Institut national du cancer de France, the National Institutes of Health (NIH), the Patient-Centered Outcomes Research Institute (PCORI) and foundations. He is a former member of the Medicare Evidence Development & Coverage Advisory Committee of the Centers for Medicare & Medicaid Services. Dr. Lewis is chair of the Data and Safety Monitoring Boards (DSMB) for federally funded, industry-sponsored clinical trials. He is a statistical reviewer for JAMA and co-editor of the JAMA section entitled “JAMA Guide to Statistics and Methods”. Dr. Lewis has authored or co-authored approximately 250 original research publications, reviews, editorials and chapters. He has been principal investigator or co-investigator in numerous research projects funded by various international, federal, state, foundation and commercial sources.


Comments are closed.